DU Suiyang. Effect observation of isosorbide mononitrate sustained release tablets combined with dopamine and furosemide on treatment of patients with heart failure caused by chronic pulmonary heart diseaseJ. Journal of Clinical Medicine in Practice, 2018, (11): 117-119. DOI: 10.7619/jcmp.201811034
|
Citation:
|
DU Suiyang. Effect observation of isosorbide mononitrate sustained release tablets combined with dopamine and furosemide on treatment of patients with heart failure caused by chronic pulmonary heart diseaseJ. Journal of Clinical Medicine in Practice, 2018, (11): 117-119. DOI: 10.7619/jcmp.201811034
|
DU Suiyang. Effect observation of isosorbide mononitrate sustained release tablets combined with dopamine and furosemide on treatment of patients with heart failure caused by chronic pulmonary heart diseaseJ. Journal of Clinical Medicine in Practice, 2018, (11): 117-119. DOI: 10.7619/jcmp.201811034
|
Citation:
|
DU Suiyang. Effect observation of isosorbide mononitrate sustained release tablets combined with dopamine and furosemide on treatment of patients with heart failure caused by chronic pulmonary heart diseaseJ. Journal of Clinical Medicine in Practice, 2018, (11): 117-119. DOI: 10.7619/jcmp.201811034
|